What an amazing night! Eagle IP was thrilled to represent the city of #HongKong as host at the @AIPLA Women in IP Global Networking event #WIPNE last Thursday. Over dinner and drinks in Sheung Wan, a group of very accomplished Hong Kong women in IP each used their voices to share stories about their career paths, dreams, lessons learned, and inspiration words for the next generation. It was amazing to re-connect with old colleagues, partners, friends, and even finally meet face-to-face (for the first time!) people we’d only known through video calls during the pandemic. Thank you so much to each person who attended. We hope for more opportunities for women in IP to connect in Hong Kong, and also around the world.
@aipla #WIPNE




Our Past Events

Recommended Insights

Foreign companies transferring IP out of China: things to know

25 October 2018
Inventions made in China Most foreign companies with R&D sites in China are aware of the fact that inventors having inventions made in China have to obtain permission before they can file patent applications outside of China for these Chinese inventions. It doesn’t matter if the owner of the business is a foreign entity. Patent […]

China Top 10 Patent Re-Examination and Invalidation Cases of 2020 CNIPA Upholds Bayer’s Rivaroxaban Patent

9 June 2021
The development of China’s approach to patents, especially those in the pharmaceutical and biotech space, has been fascinating to watch. Those of us who have practiced in the area for a long time have been frustrated by the Chinese patent office’s overly strict rules regarding patentability (e.g., high data support standard and refusal to consider […]

Can Post Filing Data Overcome Inventive Step in China?

19 November 2018
Since 2010, the Patent Re-examination Board (PRB) has published the top 10 patent invalidation cases of the year in April of each year. The selection criteria are high social concern, significant impact on the related industry, or involve difficult legal issues and important examination criteria. Below is one of the top 10 cases that discusses […]

Introducing the New USPTO Cancer Moonshot Expedited Examination Pilot Program

10 January 2023
Starting from February 1, 2023, the USPTO will begin the new Cancer Moonshot Expedited Examination Pilot Program that advances out-of-turn applications that are directed to oncology or smoking cessation. This new program will replace the Cancer Immunotherapy Pilot Program that has been in place since 2016, and covers more technologies than only cancer immunotherapies. Applications […]
Top crossarrow-right